• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up2.00% Nasdaq Up1.66%

    Infinity Pharmaceuticals, Inc. (INFI)

    -NasdaqGS
    5.92 Up 0.36(6.47%) Feb 12, 4:00PM EST
    |After Hours : 6.20 Up 0.28 (4.73%) Feb 12, 7:47PM EST
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
    Total Revenue 90,743   4,881   4,363   4,356  
    Cost of Revenue -   -   -   -  
    Gross Profit 90,743   4,881   4,363   4,356  
    Operating Expenses
    Research Development37,730  34,062  88,428  36,082  
    Selling General and Administrative9,753  9,410  8,550  7,382  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 43,260   (38,591) (92,615) (39,108)
    Income from Continuing Operations
    Total Other Income/Expenses Net75  263  (40)(17)
    Earnings Before Interest And Taxes43,335  (38,328)(92,655)(39,125)
    Interest Expense311  100  647  1,034  
    Income Before Tax43,024  (38,428)(93,302)(40,159)
    Income Tax Expense480   -   -  183  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops42,544  (38,428)(93,302)(40,342)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 42,544   (38,428) (93,302) (40,342)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 42,544   (38,428) (93,302) (40,342)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.